On Monday, Tempus AI hit an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus percentile with an upgrade to 91, an increase from 88 the day before.
Looking For The Best Stocks To Buy And Watch? Start Here
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves.
While the stock is not near a proper buy zone right now, see if it goes on to form and break out from a proper consolidation.
The company reported 0% EPS growth in the latest quarterly report, while sales growth came in at 75%.
The company holds the No. 6 rank among its peers in the Medical-Research Equipment/Services industry group. Fulgent Genetics, Schrodinger and Tempus AI are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
